Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: Pharmacokinetics and clearance by hemofiltration
被引:28
作者:
Aebi, C
论文数: 0引用数: 0
h-index: 0
机构:
CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USACHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
Aebi, C
[1
]
Headrick, CL
论文数: 0引用数: 0
h-index: 0
机构:
CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USACHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
Headrick, CL
[1
]
McCracken, GH
论文数: 0引用数: 0
h-index: 0
机构:
CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USACHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
McCracken, GH
[1
]
Lindsay, CA
论文数: 0引用数: 0
h-index: 0
机构:
CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USACHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
Lindsay, CA
[1
]
机构:
[1] CHILDRENS MED CTR, DEPT PHARM, DALLAS, TX 75235 USA
Intravenously administered ribavirin (20 mg/kg per day) was given to a neonate with disseminated adenovirus infection requiring extracorporeal membrane oxygenation and hemofiltration, Plasma concentrations at steady state were 4.81 to 8.47 mu g/ml, hemofiltration sieving coefficient was 0.85, and hemofiltration clearance (0.046 L/kg per hour) was similar to the renal clearance reported with normal kidney function, Despite low plasma concentrations, results of viral cultures were negative within 48 hours of initiation of ribavirin therapy, suggesting that plasma concentrations may not adequately predict inhibition of adenovirus replication in vivo.